Comparison of 60 or 90 mg/m(2) of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics.
作者信息
Devillier Raynier, Bertoli Sarah, Prébet Thomas, Huguet Françoise, Etienne Anne, Charbonnier Aude, Rey Jérôme, Delabesse Eric, D'Incan Evelyne, Huynh Anne, Blaise Didier, Récher Christian, Vey Norbert
机构信息
Hematology Department, Institut Paoli Calmettes, Marseille, France; Aix-Marseille University, Medecine Faculty, Marseille, France.
出版信息
Am J Hematol. 2015 Feb;90(2):E29-30. doi: 10.1002/ajh.23884. Epub 2014 Nov 19.
PMID:25363834
Abstract
摘要
Zotero 插件